230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? 230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years. Siddharth Mane / Friday, July 14, 2023 0 14386 Article rating: 4.1 The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent. Read more